Encorafenib Plus Binimetinib and Cetuximab for Previously Untreated BRAF V600E–Mutant Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal Cancer
J. Clin. Oncol 2023 Feb 10;[EPub Ahead of Print], E Van Cutsem, J Taieb, R Yaeger, T Yoshino, A Grothey, E Maiello, E Elez, J Dekervel, P Ross, A Ruiz-Casado, J Graham, T Kato, JC Ruffinelli, T André, E Carrière Roussel, I Klauck, M Groc, JC Vedovato, J TaberneroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.